Gout & crystal arthritis

1. Rheumatology (Oxford)21 Nov 2022

   Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study

   Cohort study

2. J Rheumatol15 Nov 2022

   Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study

   Cohort study

3. Arthritis Care Res (Hoboken)11 Nov 2022

   Cause‐Specific Mortality in Patients With Gout in the US Veterans Health Administration: A Matched Cohort Study

   Cohort study

4. Rheumatology (Oxford)10 Nov 2022

   Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England

   Cohort study

5. Scand J Rheumatol27 Oct 2022

   Gout in Dalarna, Sweden – a population-based study of gout occurrence and compliance to treatment guidelines

   Cohort study

6. Rheumatology (Oxford)11 Oct 2022

   Nationwide racial/ethnic disparities in US emergency department visits and hospitalizations for gout

   Cross-sectional study

7. Arthritis Care Res (Hoboken)11 Oct 2022

   Cardiovascular Disease Risk in Calcium Pyrophosphate Deposition Disease: A Nationwide Study of Veterans

   Cohort study

8. Rheumatology (Oxford)16 Sep 2022

   Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout

   Cross-sectional study

9. Arthritis Care Res (Hoboken)15 Sep 2022

   Confirming Prior and Identifying Novel Correlates of Acute Calcium Pyrophosphate Crystal Arthritis

   Case-control study

10. Rheumatology (Oxford)6 Sep 2022

    Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes

    Cohort study

11. J Rheumatol1 Sep 2022

    Examining the Characteristics of Colchicine-Induced Myelosuppression in Clinical Cases: A Systematic Review

    Meta-analysis

12. J Rheumatol1 Sep 2022

    The Burden of Gout and Its Attributable Risk Factors in the Middle East and North Africa Region, 1990 to 2019

    Secondary analysis

13. Rheumatology (Oxford)23 Aug 2022

    In patients with acute mono/oligoarthritis, a targeted ultrasound scanning protocol shows great accuracy for the diagnosis of gout and CPPD

    Diagnostic or prognostic study

14. Clin Exp Rheumatol15 Aug 2022

    Cardiovascular risk management in gout patients: do patients benefit from screening in secondary care?

    Cohort study

15. Rheumatology (Oxford)3 Aug 2022

    Ultrasonography in the prediction of gout flares: a 12-month prospective observational study

    Cohort study

16. Rheumatology (Oxford)27 Jun 2022

    Genetic contributions to female gout and hyperuricaemia using genome-wide association study and polygenic risk score analyses

    Diagnostic or prognostic study

17. Rheumatology (Oxford)22 Jun 2022

    Upregulated expression of FFAR2 and SOC3 genes is associated with gout

    Cross-sectional study

18. Clin Exp Rheumatol28 Mar 2022

    The frequency of synovitis and calcium pyrophosphate deposition with ultrasound is increased in transfusion-dependent beta-thalassaemia patients: effect of iron accumulation?

    Cross-sectional study

19. Clin Exp Rheumatol22 Mar 2022

    Association between serum free fatty acid levels and tophus in patients with gout: a cross‐sectional study

    Cross-sectional study

20. Clin Exp Rheumatol24 Feb 2022

    Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study

    Cohort study

21. Clin Exp Rheumatol29 Nov 2021

    Improvement in hepatic fibrosis estimated by Fibrosis-4 index in pegloticase treated chronic refractory gout patients

    Secondary analysis

All 301 Briefs in ExploreShowing Briefs 281–301 of 301, newest first